Skip to main content
Loading

Using transcriptomics, GWAS and single cell data together with advanced applied AIML models to uncover novel therapeutic targets

06 May 2026
Target Identification
  • Moving from association to causality in target ID

  • Cell-type resolution as the missing link towards biological relevance

  • AI/ML as a decision-support layer, not a black box

  • Operationalizing multi-omics target discovery at scale

Industry Expert
Iulian Pruteanu-Malinici, Senior Director, Bioinformatics - Pioneering Medicines